Related references
Note: Only part of the references are listed.Correction of confounding bias in non-randomized studies by appropriate weighting
Claudia Schmoor et al.
BIOMETRICAL JOURNAL (2011)
Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: A prospective magnetic resonance imaging study (vol 62, pg 609, 2010)
Nakamura
ARTHRITIS AND RHEUMATISM (2010)
Infections induced by low-dose corticosteroids in rheumatoid arthritis: A systematic literature review
Adeline Ruyssen-Witrand et al.
JOINT BONE SPINE (2010)
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Predictors of major infections in systemic lupus erythematosus
Guillermo Ruiz-Irastorza et al.
ARTHRITIS RESEARCH & THERAPY (2009)
The epidemiology of glucocorticoid-associated adverse events
Allyson K. McDonough et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
Jarrod Franklin et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Population-based assessment of adverse events associated with long-term glucocorticoid use
Jeffrey R. Curtis et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data
JAP Da Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Developments in glucocorticoid therapy
JWJ Bijlsma et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2005)
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
L Wei et al.
ANNALS OF INTERNAL MEDICINE (2004)
Glucocorticoids in the treatment of rheumatic diseases - An update on the mechanisms of action
F Buttgereit et al.
ARTHRITIS AND RHEUMATISM (2004)
Glucocorticoids and invasive fungal infections
MS Lionakis et al.
LANCET (2003)
Mechanisms involved in the side effects of glucocorticoids
H Schäcke et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology
F Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Definitions of cytomegalovirus infection and disease in transplant recipients
P Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects - A randomized, double-blind, placebo-controlled clinical trial
AA van Everdingen et al.
ANNALS OF INTERNAL MEDICINE (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Corticosteroids in the treatment of rheumatologic diseases
EF Morand
CURRENT OPINION IN RHEUMATOLOGY (2000)
Share Paper
